Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy-Reply

JAMA Surg. 2023 Jun 1;158(6):675. doi: 10.1001/jamasurg.2022.8239.
No abstract available

Publication types

  • Comment

MeSH terms

  • Breast Neoplasms* / pathology
  • Carcinoma, Ductal, Breast* / drug therapy
  • Carcinoma, Ductal, Breast* / pathology
  • Carcinoma, Intraductal, Noninfiltrating* / therapy
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Neoadjuvant Therapy
  • Neoplasm, Residual
  • Prognosis